Comparison of tegoprazan-based and proton pump inhibitor-based regimens for Helicobacter pylori eradication: a meta-analysis and systematic review
Background and aimTegoprazan (TEG) is a novel potassium-competitive acid blocker (P-CAB) that provides long-lasting acid-suppressing effects. The role of TEG-based Helicobacter pylori (H. pylori) eradication regimens in comparison to proton pump inhibitor (PPI)-based regimens requires further invest...
Saved in:
| Main Authors: | Xin Zhang, Xing Li, Jiangguo Li, Yuexia Deng, Wei Xu, Dongkui Chen, Licheng Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1580203/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Therapy for First‐Line Eradication of Helicobacter pylori: A Meta‐Analysis of Randomized Controlled Trials
by: Daniel Martin Simadibrata, et al.
Published: (2025-03-01) -
Tegoprazan dual and quadruple therapy for Helicobacter pylori eradication: a prospective, randomized controlled trial in Beijing, China
by: Jianping Cheng, et al.
Published: (2025-08-01) -
Compliance with Helicobacter pylori eradication: modern approaches to increase in commitment and the results of own research
by: T. A. Ilchishina
Published: (2021-06-01) -
Standard First-line Triple Therapy for Helicobacter pylori Infection: A Comparison of Eradication Rates Based on Timing of Administration of Proton Pump Inhibitors
by: Seong Ju Lee, et al.
Published: (2018-06-01) -
Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker– and Proton Pump Inhibitor–Based Bismuth Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis
by: Iqbal Taufiqqurrachman, et al.
Published: (2025-01-01)